| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Cheif Executive Officer | CEO +4 more
2 companies
Fried Robert N is a Chief Executive Officer at Niagen Bioscience, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 10 buys and 0 sells.
Estimated insider holdings value: $4.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 31, 2023 | NAGE Niagen Bioscience, Inc. | Chief Executive Officer | Buy | 7,000 | $1.42 | $9,940.00 | +8.0% | +11.3% | +100.7% | |
| Sep 30, 2022 | NAGE Niagen Bioscience, Inc. | Cheif Executive Officer | Buy | 80,000 | $1.25 | $100,000.00 | +9.0% | +31.7% | +18.7% | |
| Mar 16, 2022 | NAGE Niagen Bioscience, Inc. | CEO | Buy | 25,000 | $2.16 | $54,000.00 | +39.7% | -17.1% | -24.9% | |
| May 13, 2021 | NAGE Niagen Bioscience, Inc. | CEO | Buy | 10,000 | $6.65 | $66,500.00 | +18.9% | +30.2% | -74.6% | |
| May 19, 2020 | NAGE Niagen Bioscience, Inc. | CEO | Buy | 1,000 | $4.69 | $4,690.00 | - | - | - | |
| Nov 14, 2019 | NAGE Niagen Bioscience, Inc. | CEO | Buy | 10,000 | $3.09 | $30,900.00 | +0.7% | - | - | |
| Aug 23, 2019 | NAGE Niagen Bioscience, Inc. | CEO | Buy | 2,500 | $4.03 | $10,075.00 | +0.2% | - | - | |
| May 21, 2019 | NAGE Niagen Bioscience, Inc. | CEO | Buy | 2,253 | $4.43 | $9,980.79 | +0.2% | - | - | |
| Mar 15, 2019 | NAGE Niagen Bioscience, Inc. | CEO | Buy | 5,000 | $3.80 | $19,000.00 | +0.4% | - | - | |
| Aug 15, 2017 | NAGE Niagen Bioscience, Inc. | President, Chief Strategy Off. | Buy | 10,000 | $3.15 | $31,500.00 | +1.7% | - | - |